Report of Foreign Issuer (6-k)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

May, 2020

 

Commission File Number:  000-50492

 

 CORDOVACANN CORP.

(Translation of registrant's name into English)

 

 

217 Queen Street West, Suite 401,

Toronto, Ontario, M5V 0R2, Canada

 (Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

[ X ] Form 20-F  [   ] Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [   ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [   ]

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes [   ]       No [ X ]

 

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

 

 

 

 

Exhibits

 

Exhibit No.	Description
99.1	Financial Statements for the Three and Nine Months Ended March 31, 2020 and 2019
99.2	Management’s Discussion and Analysis
99.3	Form 52-109FV2 - Certification of Interim Filing – CEO
99.4	Form 52-109FV2 - Certification of Interim Filing – CFO

 

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

	CORDOVACANN CORP.
Date: May 29, 2020	By:	/s/ Ashish Kapoor
		Ashish Kapoor Chief Financial Officer